nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexfenfluramine—CYP2C19—Rosuvastatin—atherosclerosis	0.0969	0.112	CbGbCtD
Dexfenfluramine—CYP2C19—Simvastatin—atherosclerosis	0.0901	0.104	CbGbCtD
Dexfenfluramine—CYP2C19—Lovastatin—atherosclerosis	0.0881	0.102	CbGbCtD
Dexfenfluramine—CYP2D6—Niacin—atherosclerosis	0.0866	0.1	CbGbCtD
Dexfenfluramine—CYP2C9—Rosuvastatin—atherosclerosis	0.0806	0.093	CbGbCtD
Dexfenfluramine—CYP2C9—Simvastatin—atherosclerosis	0.0749	0.0865	CbGbCtD
Dexfenfluramine—CYP2C9—Pravastatin—atherosclerosis	0.0733	0.0846	CbGbCtD
Dexfenfluramine—CYP2C9—Lovastatin—atherosclerosis	0.0733	0.0846	CbGbCtD
Dexfenfluramine—CYP2D6—Simvastatin—atherosclerosis	0.0685	0.0791	CbGbCtD
Dexfenfluramine—CYP2D6—Lovastatin—atherosclerosis	0.067	0.0774	CbGbCtD
Dexfenfluramine—CYP2D6—Pravastatin—atherosclerosis	0.067	0.0774	CbGbCtD
Dexfenfluramine—Cinacalcet—CASR—atherosclerosis	0.0132	1	CrCbGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.64e-05	0.000219	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CXCL8—atherosclerosis	2.64e-05	0.000219	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	2.62e-05	0.000217	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—APOB—atherosclerosis	2.59e-05	0.000215	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.59e-05	0.000215	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.58e-05	0.000214	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.57e-05	0.000213	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.57e-05	0.000213	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.56e-05	0.000212	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ALOX5—atherosclerosis	2.55e-05	0.000212	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	2.54e-05	0.000211	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	2.54e-05	0.000211	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ALOX15—atherosclerosis	2.54e-05	0.000211	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—APOA2—atherosclerosis	2.54e-05	0.000211	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ALOX5—atherosclerosis	2.53e-05	0.00021	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SOCS3—atherosclerosis	2.53e-05	0.00021	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—GSTM1—atherosclerosis	2.52e-05	0.000209	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ABCG5—atherosclerosis	2.51e-05	0.000208	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.51e-05	0.000208	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ABCA1—atherosclerosis	2.49e-05	0.000207	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—NAMPT—atherosclerosis	2.49e-05	0.000206	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—LPL—atherosclerosis	2.48e-05	0.000205	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.48e-05	0.000205	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—LIPC—atherosclerosis	2.48e-05	0.000205	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—APOC3—atherosclerosis	2.46e-05	0.000204	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PDGFB—atherosclerosis	2.45e-05	0.000203	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MMP3—atherosclerosis	2.44e-05	0.000203	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—LDLR—atherosclerosis	2.44e-05	0.000203	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IGF2—atherosclerosis	2.43e-05	0.000202	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—LPA—atherosclerosis	2.43e-05	0.000201	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—GPX1—atherosclerosis	2.42e-05	0.0002	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—AGT—atherosclerosis	2.39e-05	0.000198	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CETP—atherosclerosis	2.39e-05	0.000198	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—APOB—atherosclerosis	2.36e-05	0.000196	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CD36—atherosclerosis	2.35e-05	0.000195	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—BGN—atherosclerosis	2.35e-05	0.000195	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—LEP—atherosclerosis	2.34e-05	0.000194	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—APOE—atherosclerosis	2.34e-05	0.000194	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—CXCL8—atherosclerosis	2.34e-05	0.000194	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.34e-05	0.000194	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.33e-05	0.000194	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—APOA5—atherosclerosis	2.33e-05	0.000193	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—EDN1—atherosclerosis	2.33e-05	0.000193	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CAV1—atherosclerosis	2.32e-05	0.000193	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—APOA1—atherosclerosis	2.32e-05	0.000192	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCL5—atherosclerosis	2.31e-05	0.000191	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—NAMPT—atherosclerosis	2.29e-05	0.00019	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—SCARB1—atherosclerosis	2.29e-05	0.00019	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—LIPC—atherosclerosis	2.28e-05	0.000189	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—NAMPT—atherosclerosis	2.27e-05	0.000188	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—APOC3—atherosclerosis	2.26e-05	0.000188	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.26e-05	0.000187	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.26e-05	0.000187	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—LIPC—atherosclerosis	2.26e-05	0.000187	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—LPL—atherosclerosis	2.26e-05	0.000187	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—LDLR—atherosclerosis	2.25e-05	0.000186	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—APOC3—atherosclerosis	2.24e-05	0.000186	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	2.24e-05	0.000186	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—ESR1—atherosclerosis	2.24e-05	0.000186	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—MTHFR—atherosclerosis	2.23e-05	0.000185	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—LDLR—atherosclerosis	2.23e-05	0.000185	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.23e-05	0.000185	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.22e-05	0.000184	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—F2—atherosclerosis	2.21e-05	0.000183	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CETP—atherosclerosis	2.2e-05	0.000182	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.19e-05	0.000182	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PRKCG—atherosclerosis	2.19e-05	0.000182	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.19e-05	0.000182	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PPARA—atherosclerosis	2.19e-05	0.000181	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CETP—atherosclerosis	2.18e-05	0.000181	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ALOX5—atherosclerosis	2.16e-05	0.000179	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—HMGCR—atherosclerosis	2.16e-05	0.000179	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—HMOX1—atherosclerosis	2.14e-05	0.000177	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SPP1—atherosclerosis	2.14e-05	0.000177	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CXCL8—atherosclerosis	2.13e-05	0.000176	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—AGT—atherosclerosis	2.12e-05	0.000176	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3CG—atherosclerosis	2.12e-05	0.000175	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—SCARB1—atherosclerosis	2.1e-05	0.000174	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—SCARB1—atherosclerosis	2.09e-05	0.000173	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—APOE—atherosclerosis	2.08e-05	0.000172	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CAV1—atherosclerosis	2.06e-05	0.000171	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—APOA1—atherosclerosis	2.05e-05	0.00017	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—APOB—atherosclerosis	2.05e-05	0.00017	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.03e-05	0.000168	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—MAPK3—atherosclerosis	2.03e-05	0.000168	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—INS—atherosclerosis	2e-05	0.000166	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2e-05	0.000166	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GSTM1—atherosclerosis	1.99e-05	0.000165	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.99e-05	0.000165	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PDGFB—atherosclerosis	1.98e-05	0.000164	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CCL2—atherosclerosis	1.97e-05	0.000163	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.97e-05	0.000163	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—LPL—atherosclerosis	1.96e-05	0.000162	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.95e-05	0.000161	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.94e-05	0.000161	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IGF1—atherosclerosis	1.94e-05	0.000161	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—AGT—atherosclerosis	1.93e-05	0.00016	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.93e-05	0.00016	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—LIPC—atherosclerosis	1.93e-05	0.00016	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.92e-05	0.00016	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—APOC3—atherosclerosis	1.92e-05	0.000159	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GPX1—atherosclerosis	1.91e-05	0.000158	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—LDLR—atherosclerosis	1.9e-05	0.000158	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—LEP—atherosclerosis	1.89e-05	0.000157	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—APOE—atherosclerosis	1.89e-05	0.000157	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CG—atherosclerosis	1.87e-05	0.000155	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CAV1—atherosclerosis	1.87e-05	0.000155	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—APOA1—atherosclerosis	1.87e-05	0.000155	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CETP—atherosclerosis	1.86e-05	0.000154	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CD36—atherosclerosis	1.86e-05	0.000154	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SERPINE1—atherosclerosis	1.84e-05	0.000153	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PPARG—atherosclerosis	1.81e-05	0.00015	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ESR1—atherosclerosis	1.81e-05	0.00015	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—F2—atherosclerosis	1.78e-05	0.000148	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.78e-05	0.000148	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.78e-05	0.000147	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—INS—atherosclerosis	1.77e-05	0.000147	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.77e-05	0.000147	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—MTHFR—atherosclerosis	1.76e-05	0.000146	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—NOS3—atherosclerosis	1.76e-05	0.000146	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.76e-05	0.000146	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.73e-05	0.000144	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PPARA—atherosclerosis	1.73e-05	0.000143	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CG—atherosclerosis	1.71e-05	0.000142	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—HMGCR—atherosclerosis	1.68e-05	0.00014	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—AGT—atherosclerosis	1.67e-05	0.000139	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.65e-05	0.000137	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—APOE—atherosclerosis	1.64e-05	0.000136	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—MAPK3—atherosclerosis	1.63e-05	0.000136	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—ALB—atherosclerosis	1.63e-05	0.000135	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CAV1—atherosclerosis	1.63e-05	0.000135	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—APOA1—atherosclerosis	1.62e-05	0.000134	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—INS—atherosclerosis	1.62e-05	0.000134	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCL2—atherosclerosis	1.59e-05	0.000132	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—APOB—atherosclerosis	1.58e-05	0.000131	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IGF1—atherosclerosis	1.56e-05	0.00013	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CXCL8—atherosclerosis	1.56e-05	0.000129	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—NOS3—atherosclerosis	1.56e-05	0.000129	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.54e-05	0.000128	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.52e-05	0.000126	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.52e-05	0.000126	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—LPL—atherosclerosis	1.51e-05	0.000125	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.51e-05	0.000125	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—AKT1—atherosclerosis	1.5e-05	0.000125	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ABCA1—atherosclerosis	1.5e-05	0.000124	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SERPINE1—atherosclerosis	1.48e-05	0.000123	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—IL6—atherosclerosis	1.48e-05	0.000123	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CG—atherosclerosis	1.48e-05	0.000123	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GPX1—atherosclerosis	1.47e-05	0.000122	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—APOB—atherosclerosis	1.45e-05	0.000121	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—APOB—atherosclerosis	1.44e-05	0.00012	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CD36—atherosclerosis	1.44e-05	0.000119	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PPARG—atherosclerosis	1.43e-05	0.000119	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PTGS2—atherosclerosis	1.42e-05	0.000118	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NOS3—atherosclerosis	1.42e-05	0.000117	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.42e-05	0.000117	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MMP9—atherosclerosis	1.41e-05	0.000117	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.4e-05	0.000116	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—INS—atherosclerosis	1.4e-05	0.000116	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—NFKB1—atherosclerosis	1.39e-05	0.000116	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—LPL—atherosclerosis	1.39e-05	0.000115	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—LPL—atherosclerosis	1.38e-05	0.000114	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MAPK8—atherosclerosis	1.37e-05	0.000114	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—AKT1—atherosclerosis	1.37e-05	0.000113	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—MTHFR—atherosclerosis	1.36e-05	0.000113	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GPX1—atherosclerosis	1.36e-05	0.000112	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GPX1—atherosclerosis	1.34e-05	0.000111	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PPARA—atherosclerosis	1.33e-05	0.000111	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CD36—atherosclerosis	1.32e-05	0.000109	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CD36—atherosclerosis	1.31e-05	0.000108	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—AGT—atherosclerosis	1.29e-05	0.000107	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—HMOX1—atherosclerosis	1.29e-05	0.000107	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ALB—atherosclerosis	1.29e-05	0.000107	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—APOE—atherosclerosis	1.27e-05	0.000105	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—VEGFA—atherosclerosis	1.27e-05	0.000105	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CXCL8—atherosclerosis	1.26e-05	0.000104	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CAV1—atherosclerosis	1.25e-05	0.000104	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—STAT3—atherosclerosis	1.25e-05	0.000104	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—APOA1—atherosclerosis	1.25e-05	0.000104	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.25e-05	0.000104	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—MTHFR—atherosclerosis	1.24e-05	0.000103	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—APOB—atherosclerosis	1.23e-05	0.000102	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—NOS3—atherosclerosis	1.23e-05	0.000102	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PPARA—atherosclerosis	1.23e-05	0.000102	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PPARA—atherosclerosis	1.22e-05	0.000101	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—AKT1—atherosclerosis	1.21e-05	0.000101	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTM1—atherosclerosis	1.2e-05	9.94e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MAPK3—atherosclerosis	1.2e-05	9.92e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—IL6—atherosclerosis	1.2e-05	9.91e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—AGT—atherosclerosis	1.19e-05	9.85e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—AGT—atherosclerosis	1.18e-05	9.77e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—LPL—atherosclerosis	1.18e-05	9.76e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—APOE—atherosclerosis	1.16e-05	9.65e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TGFB1—atherosclerosis	1.16e-05	9.63e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—APOE—atherosclerosis	1.15e-05	9.57e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CAV1—atherosclerosis	1.15e-05	9.57e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—APOA1—atherosclerosis	1.15e-05	9.54e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GPX1—atherosclerosis	1.15e-05	9.52e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CAV1—atherosclerosis	1.14e-05	9.48e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	1.14e-05	9.47e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—APOA1—atherosclerosis	1.14e-05	9.46e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MMP9—atherosclerosis	1.14e-05	9.43e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	1.12e-05	9.33e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PTGS2—atherosclerosis	1.12e-05	9.32e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CD36—atherosclerosis	1.12e-05	9.27e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	1.11e-05	9.17e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PPARG—atherosclerosis	1.1e-05	9.14e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	1.1e-05	9.14e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—INS—atherosclerosis	1.08e-05	8.97e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—MTHFR—atherosclerosis	1.06e-05	8.79e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.05e-05	8.71e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	1.04e-05	8.64e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PPARA—atherosclerosis	1.04e-05	8.62e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	1.02e-05	8.46e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PPARG—atherosclerosis	1.01e-05	8.41e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—STAT3—atherosclerosis	1.01e-05	8.38e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—AGT—atherosclerosis	1.01e-05	8.35e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PPARG—atherosclerosis	1.01e-05	8.34e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—INS—atherosclerosis	9.95e-06	8.25e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ALB—atherosclerosis	9.92e-06	8.22e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—APOE—atherosclerosis	9.86e-06	8.18e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—INS—atherosclerosis	9.86e-06	8.18e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CAV1—atherosclerosis	9.77e-06	8.1e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—APOA1—atherosclerosis	9.75e-06	8.08e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	9.66e-06	8.01e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—NOS3—atherosclerosis	9.48e-06	7.86e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	9.37e-06	7.77e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ALB—atherosclerosis	9.12e-06	7.56e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ALB—atherosclerosis	9.04e-06	7.5e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	8.9e-06	7.38e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IL6—atherosclerosis	8.75e-06	7.26e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—NOS3—atherosclerosis	8.72e-06	7.23e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PTGS2—atherosclerosis	8.67e-06	7.19e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—NOS3—atherosclerosis	8.65e-06	7.17e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PPARG—atherosclerosis	8.59e-06	7.12e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—INS—atherosclerosis	8.43e-06	6.99e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—AKT1—atherosclerosis	8.07e-06	6.69e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PTGS2—atherosclerosis	7.98e-06	6.62e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PTGS2—atherosclerosis	7.91e-06	6.56e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ALB—atherosclerosis	7.73e-06	6.41e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NOS3—atherosclerosis	7.39e-06	6.13e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—AKT1—atherosclerosis	7.15e-06	5.93e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IL6—atherosclerosis	7.06e-06	5.85e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PTGS2—atherosclerosis	6.76e-06	5.6e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—AKT1—atherosclerosis	6.51e-06	5.4e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—AKT1—atherosclerosis	5.65e-06	4.69e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—AKT1—atherosclerosis	4.36e-06	3.61e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—AKT1—atherosclerosis	4.01e-06	3.32e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—AKT1—atherosclerosis	3.98e-06	3.3e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—AKT1—atherosclerosis	3.4e-06	2.82e-05	CbGpPWpGaD
